CN100528180C - Medication for treating diseases of cranial nerve and cerebrovascular, and preparation method - Google Patents

Medication for treating diseases of cranial nerve and cerebrovascular, and preparation method Download PDF

Info

Publication number
CN100528180C
CN100528180C CNB2005100429944A CN200510042994A CN100528180C CN 100528180 C CN100528180 C CN 100528180C CN B2005100429944 A CNB2005100429944 A CN B2005100429944A CN 200510042994 A CN200510042994 A CN 200510042994A CN 100528180 C CN100528180 C CN 100528180C
Authority
CN
China
Prior art keywords
parts
herba
tremella
medicine
lentinus edodes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2005100429944A
Other languages
Chinese (zh)
Other versions
CN1726947A (en
Inventor
李悦
宋维生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JINYUE BIOENGINEERING CO Ltd SHAANXI
Original Assignee
JINYUE BIOENGINEERING CO Ltd SHAANXI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JINYUE BIOENGINEERING CO Ltd SHAANXI filed Critical JINYUE BIOENGINEERING CO Ltd SHAANXI
Priority to CNB2005100429944A priority Critical patent/CN100528180C/en
Publication of CN1726947A publication Critical patent/CN1726947A/en
Application granted granted Critical
Publication of CN100528180C publication Critical patent/CN100528180C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A Chinese medicine for treating cerebral nervous diseases and cerebrovascular diseases is proportionally prepared from 7 Chinese-medicinal materials including dandelion herb, Chuan-xiong rhizome, snow lotus flower, tremella, etc through immersing, decocting, filtering and concentrating.

Description

A kind of medicine for the treatment of cranial nerve and cerebrovascular disease and preparation method thereof
Technical field
The invention belongs to the field of Chinese medicines, relate to limited medicine of a kind of reparation that is mainly used in brain neuroblastoma, hemiplegia, brainpan damage and limb activity and preparation method thereof.
Background technology
Encephalopathy is a kind of commonly encountered diseases, and the power of charging is the strongest, and sickness rate is the highest, and the rate of dieing is the highest.More than 40 national all kinds of diseases cause and come front three in the rate of dying in the world through investigation, and the number of dieing because of hemiplegia accounts for 22.6% of annual total death toll.The annual minimum life that will seize 1,000 ten thousand above people in the whole world is so this disease is acknowledged as one of " four big killers ".The Chinese and western drugs of treatment encephalopathy is a lot of at present, the treatment face of these medicines is generally narrower, particularly reparation, hemiplegia, the brainpan to cranial nerve damages or the limited disease of limb activity, merely can only relief of symptoms with doctor trained in Western medicine or tcm therapy, and therapy of combining Chinese and Western medicine, rescued life and do not controlled disease, so poor effect.Also there is not ideal medicament at present at above-mentioned symptom.
Summary of the invention
The objective of the invention is to propose limited medicine of a kind of reparation, hemiplegia, brainpan damage and limb activity that is mainly used in brain neuroblastoma and preparation method thereof, it has solved the existing traditional Chinese medical science can only activating blood circulation to dissipate blood stasis, the technical problem of the treatment that doctor trained in Western medicine can only blood vessel dilating.
Implementation of the present invention is:
A kind of medicine for the treatment of cranial nerve and cerebrovascular disease is mainly made by the crude drug of following parts by weight: Herba Taraxaci 10-35 part, Herba Taxilli 8-35 part, Rhizoma Chuanxiong 5-16 part, Lentinus Edodes 10-25 part, agrocyb eaegerita 10-30 part, Herba Saussureae Involueratae 12-24 part.Also can include the Tremella of 5~30 parts by weight in its crude drug.
The preferable consumption of above-mentioned each crude drug is: 10~20 parts of Herba Taraxacis, 10~20 parts of Herba Taxillis, 8~15 parts of Rhizoma Chuanxiongs, 15~17 parts on Lentinus Edodes, 16~20 parts of agrocyb eaegerita, 15~18 parts of Herba Saussureae Involuerataes.Also can include the Tremella of 10~15 parts by weight in its crude drug.
The optimum amount of above-mentioned each crude drug is: 15 parts of Herba Taraxacis, 12 parts in Tremella, 15 parts of Herba Taxillis, 10 parts of Rhizoma Chuanxiongs, 16 parts on Lentinus Edodes, 18 parts of agrocyb eaegerita, 16 parts of Herba Saussureae Involuerataes.
The preparation method of the medicine of above-mentioned treatment cranial nerve and cerebrovascular disease comprises the following steps:
1) standby by following parts by weight proportioning weighting raw materials: 5~30 parts in Tremella, Herba Taraxaci 10-35 part, Herba Taxilli 8-35 part, Rhizoma Chuanxiong 5-16 part, Lentinus Edodes 10-25 part, agrocyb eaegerita 10-30 part, Herba Saussureae Involueratae 12-24 part;
2) get Tremella, Lentinus Edodes, agrocyb eaegerita, Herba Saussureae Involueratae in proportion 1: 5 water mix, room temperature soak down 3~6 hours standby;
3) be incubated 40~120 minutes down at 50~80 ℃;
4) add Rhizoma Chuanxiong, Herba Taxilli, Herba Taraxaci, temperature is raised to 80~100 ℃, and slow fire boiled 1~3 hour;
5) filter, medicinal liquid is concentrated to 1/10 of total amount promptly can be made into oral liquid.
The best performing step of above-mentioned preparation method is as follows:
1) standby by following parts by weight proportioning weighting raw materials: 10~15 parts in Tremella, 10~20 parts of Herba Taraxacis, 10~20 parts of Herba Taxillis, 8~15 parts of Rhizoma Chuanxiongs, 15~17 parts on Lentinus Edodes, 16~20 parts of agrocyb eaegerita, 15~18 parts of Herba Saussureae Involuerataes;
2) get Tremella, Lentinus Edodes, agrocyb eaegerita, Herba Saussureae Involueratae in proportion 1: 5 water mix, room temperature soak down 4 hours standby;
3) be incubated 45 minutes down at 55~60 ℃;
4) add Rhizoma Chuanxiong, Herba Taxilli, Herba Taraxaci, temperature is raised to 90~100 ℃, and slow fire boiled 1~2 hour;
5) filter, medicinal liquid is concentrated to 1/10 of total amount promptly can be made into oral liquid.
Viewpoint with " international 4G therapy " and " modernization of Chinese medicine ", the research of applicant surplus ten year is clinical, work out a kind of reparation cranial nerves rehabilitation medicine---cranial nerve sheath enzyme (Enigmols) and preparation method, having overcome the traditional Chinese medical science can only activating blood circulation to dissipate blood stasis, doctor trained in Western medicine can only blood vessel dilating the treatment limitation, embodied the innovative idea of " repair cerebral nerve and be this, auxiliary blood, brain, the heart, kidney are ruled together, and stop sequela ".
This product belongs to the weak base type, arrive former focus after, remove rapidly " acid poison ", alleviate the calcium ion overload, stop neuron further downright bad, increase neurotrophic factor ribonucleic acid (RNA) quantity, DNA skin base cell and gene, promote that neurocyte grows new first bud, feeler, increase the cerebral gray matter element, these yuan bud and feeler and Toplink are connected with each other, and form many new nerve net, quick active residue brain cell is fully repaired impaired nerve and regenerates.Impel a large amount of compensatory vessel open simultaneously, blood enters from the compensatory blood vessel of brain cell periphery, has increased the supply and the oxygen uptake of blood, and it is external that especially hemorrhage and embolus is got rid of rapidly, the effect of activating blood circulation to dissipate blood stasis, removing heat from blood, hemostasis, clean blood are arranged, enriching blood.Make original focus more and more littler, a large amount of cranial nerve cells have been lived again.After calculating 21 days, the injured nerve reparation will reach about 17%.
The present invention mixes Lentinus Edodes, agrocyb eaegerita, Herba Taxilli, Herba Saussureae Involueratae according to above-mentioned treatment mechanism in 55~60 ℃ of temperature, chemical combination is aphingolipid.Tremella contains abundant colloid, phospholipid, sterin, to brain cell and the nutritious effect of neurocyte, thereby supplementing the brain.Herba Taraxaci is rich in lecithin, and Rhizoma Chuanxiong is rich in the gallbladder element, is the synthetic necessary composition of cerebral gray matter, and Herba Taxilli is rich in inositol.Soak by mixing once more, synthetic Toplink, peptide is the principal element by the brain barrier, the nerve sheath enzyme of having derived simultaneously.
Herba Taraxaci Herba Taraxaci: another name Herba crotalariae albidae, grandmother's fourth, milk grass, for feverfew Herba Taraxaci Taraxacum mongolicum Hand.-Mazz. and belong to the whole herb with root of various plants together.Select for use Herba Taraxaci because of its hardship, sweet, cold, the effect of tool detoxification and promoting urination, removing pathogenic heat from blood and inducing diuresis.Modern Chinese medicine thinks that the Herba Taraxaci herb contains taraxasterol taraxasterol, choline, inulin and pectin etc., can participate in containing the compound recipe of ketone, ketone, the drug matching of active alkali class, has the microcirculation improvement effect.
Rhizoma Chuanxiong: this product is the dry rhizome of samphire Rhizoma Chuanxiong Ligusticum chuanxiong Hort..Selecting Rhizoma Chuanxiong for use is because of its suffering, temperature, the effect of tool blood-activating and qi-promoting, wind-expelling pain-stopping.Modern Chinese medicine thinks that the Rhizoma Chuanxiong alkaloid in the Rhizoma Chuanxiong can be benumbed nervus centralis, antalgic and sedative, excited respiratory center, vasomotor center are directly expanded peripheral vessels, the blood flow of coronary blood flow increasing and lower limb body, cholesterol reducing, blood fat reducing, blood pressure lowering; Can also reduce the platelet aggregation degree, promote the dissolving of blood inner fibrin, anti-tampon has spasmolysis.In this prescription, Rhizoma Chuanxiong is rich in active alkaloid, and it is more obvious to make Herba Taraxaci improve sanguimotor effect, promotes each prescription medicine complementary action to strengthen, and improves curative effect, the collaborative effect that reaches the radical cure cardiovascular and cerebrovascular disease.
Herba Saussureae Involueratae Herba Saussureae Involucratae: the another name Saussurea involucrata is the wounded in the battle Herb of feverfew Saussurea medusa Maxim. Saussurea medusaMaxim..Its main component is globulariacitrin, xuelianlactone, alkaloid, volatile oil, polysaccharide.Herba Saussureae Involueratae has the effect of warming the kidney to invigorate YANG, dispelling cold by warming the meridian, warming the lung to resolve fluid-retention, expelling wind and removing dampness.
Herba Taxilli: this product is the dry stem and branch with leaf of Loranthaceae plant Herba Taxilli Taxillus chinensis (DC.) Danser.Selecting Herba Taxilli for use is because of its hardship, sweet, flat, tool dredge the meridian passage, the smart effect of the benefit that nourishes blood.Herba Taxilli can expansion artery, increase blood supply flow coronarius, has the effect of blood fat reducing, blood sugar lowering, cholesterol reducing, is the good medicine of thromboembolism.
Tremella: the another name Tremella is the sporophore of Tremellaceae plant Tremella Tremella fuciformis Berk..Tremella has heat clearing away, white more activating YANG and eliminating stagnation, heart tonifying and brain strengthening, refresh oneself enrich blood, effect such as QI invigorating.Cure mainly chest pain radiating to the back, the thoracic obstruction of breathing hard, coronary atherosclerosis, diseases such as heart stricture of vagina pain.It contains abundant colloid, multivitamin, inorganic salt, aminoacid, acid different polysaccharide and several mineral materials.Clinical proof, Tremella can improve body immunity, enriching yin and nourishing kidney, lung moistening brain-strengthening, nourishing the stomach QI invigorating, bring high blood pressure down, blood fat and certain anti-cancer and kill cancer action is arranged.
Agrocyb eaegerita: belong to excrement umbrella section, have another name called Agroeybe cylindracea mycelia, tea mushroom, oil tea mushroom, refreshing mushroom, the new mushroom of tea, the traditional Chinese medical science thinks that this mushroom property is sweet, warm, nontoxic, and the effect of invigorating the spleen to arrest diarrhea is arranged, and defying age, cholesterol reducing, anti-cancer and anticancer special role are arranged.Agrocyb eaegerita contains 17 seed amino acids of needed by human body, and wherein human body is can not synthetic amino acid content high especially, contains 10 several mineral materials trace element and polysaccharide in addition.
Lentinus Edodes belongs to Pleurotaceae, has another name called Lentinus Edodes, fragrant letter, fragrant wild rice, vertebra young pilose antler, and contained lentinan has antitumor action; Adenine and choline can prevent liver cirrhosis and sclerosis of blood vessels; The tyrosine oxidase has the effect that brings high blood pressure down, but the generation of double stranded RNA inducing interferon has antivirus action.Among the people Lentinus Edodes is used for detoxifcation, stomach reinforcing gas and control the wind removing blood stasis.
Selected Tremella, agrocyb eaegerita, the Lentinus Edodes of the present invention can also strengthen the immunity of human body.
More than each medicine share, can nourshing blood and promoting blood circulation, repair damagedly, eliminate the dirty pathogenic factor, QI and blood regulating makes the rapid rehabilitation of all kinds of cardiovascular and cerebrovascular diseases, radical cure.
The present invention is pure traditional Chinese biological preparation, absorb fast, drug effect is rapid, active constituent content is high, dose is few, features good taste, safely, have no side effect and taking convenience.The present invention is not limited only to oral liquid, and the peroral dosage form of other form (decoction, tablet, powder etc.) also belongs to category of the present invention.
Each related in above-mentioned preparation method technological parameter all obtains through after a large amount of contrast tests, according to said method can extract the effective ingredient in the medicine to greatest extent, and the steady quality of gained medicine.
In view of above-mentioned pharmacology, this medicine is effective in cure to diseases such as cerebrovascular, cardiovascular, high blood viscosity, cerebral hemorrhage, cerebral infarction, cerebral embolism, hemiplegia, facial hemiparalysis, numb limbs and tense tendons, insomnia forgetfulness, myocardial infarction, alzheimer disease, extremity tremble.
The specific embodiment
Embodiment 1:
15 parts of Herba Taraxacis, 12 parts in Tremella, 15 parts of Herba Taxillis, 10 parts of Rhizoma Chuanxiongs, 16 parts on Lentinus Edodes, 18 parts of agrocyb eaegerita, 16 parts of Herba Saussureae Involuerataes.
Its preparation method is:
1) by weight proportioning to take by weighing Herba Taraxaci, Tremella, Herba Taxilli, Rhizoma Chuanxiong, Lentinus Edodes, agrocyb eaegerita, Herba Saussureae Involueratae standby;
2) get Tremella, Lentinus Edodes, agrocyb eaegerita, Herba Saussureae Involueratae in proportion 1: 5 water mix, room temperature soak down 4 hours standby;
3) be incubated 45 minutes down at 55~60 ℃;
4) add Rhizoma Chuanxiong, Herba Taxilli, Herba Taraxaci, temperature is raised to 90~100 ℃, and slow fire boiled 1~2 hour;
5) filter, medicinal liquid is concentrated to 1/10 of total amount promptly can be made into oral liquid.
Embodiment 2:
Get 10 parts of Herba Taraxacis, 5 parts in Tremella, 8 parts of Herba Taxillis, 5 parts of Rhizoma Chuanxiongs, 10 parts on Lentinus Edodes, 10 parts of agrocyb eaegerita, 12 parts of Herba Saussureae Involuerataes.
1) by weight proportioning to take by weighing Herba Taraxaci, Tremella, Herba Taxilli, Rhizoma Chuanxiong, Lentinus Edodes, agrocyb eaegerita, Herba Saussureae Involueratae standby;
2) get Tremella, Lentinus Edodes, agrocyb eaegerita, Herba Saussureae Involueratae in proportion 1: 5 water mix, room temperature soak down 3 hours standby;
3) be incubated 40 minutes down at 50 ℃;
4) add Rhizoma Chuanxiong, Herba Taxilli, Herba Taraxaci, temperature is raised to 80 ℃, and slow fire boiled 1 hour;
5) filter, medicinal liquid is concentrated to 1/10 of total amount promptly can be made into oral liquid.
Embodiment 3:
Get 35 parts of Herba Taraxacis, 30 parts in Tremella, 35 parts of Herba Taxillis, 16 parts of Rhizoma Chuanxiongs, 25 parts on Lentinus Edodes, 30 parts of agrocyb eaegerita, 24 parts of Herba Saussureae Involuerataes.
1) proportioning takes by weighing Herba Taraxaci by weight, Tremella, and Herba Taxilli, Rhizoma Chuanxiong, Lentinus Edodes, agrocyb eaegerita, Herba Saussureae Involueratae is standby;
2) get Tremella, Lentinus Edodes, agrocyb eaegerita, Herba Saussureae Involueratae in proportion 1: 5 water mix, room temperature soak down 4 hours standby;
3) be incubated 45 minutes down at 60 ℃;
4) add Rhizoma Chuanxiong, Herba Taxilli, Herba Taraxaci, temperature is raised to 100 ℃, and slow fire boiled 2 hours;
5) filter, medicinal liquid is concentrated to 1/10 of total amount promptly can be made into oral liquid.
Embodiment 4:
Get 10 parts of Herba Taraxacis, 10 parts in Tremella, 10 parts of Herba Taxillis, 8 parts of Rhizoma Chuanxiongs, 15 parts on Lentinus Edodes, 16 parts of agrocyb eaegerita, 15 parts of Herba Saussureae Involuerataes.
Preparation method is with embodiment 1.
Clinical trial:
Subjects is totally 103 examples, male's 72 examples wherein, women's 31 examples; Age 32 was to 68 years old; The course of disease 3 to 18 years; Cardiovascular diseases's 17 examples, encephalopathy 86 examples (severe disease 55 examples); " apoplexy diagnosis efficacy assessment standard " (the trying) that diagnostic criteria is drafted formulation with reference to " all kinds of cerebrovascular disease diagnosis main points " and State Administration of Traditional Chinese Medicine's encephalopathy emergency case scientific research cooperative groups of the 4th national cerebrovascular academic conference revision of nineteen ninety-five Chinese Medical Association; Test group is taken oral liquid of the present invention, and specification is that 10ml/ props up.Each 1,3 times on the 1st, 8 weeks were 1 course of treatment.
Clinical test results sees Table 1.
Table 1
The example number Recovery from illness Produce effects Effectively Invalid Total effective rate
103 99(96%) 3(3%) 1(1%) 0(0%) 100%
Its curative effect of evidence is significant.
Toxicity test:
Test drug is a preparation of the present invention, and every 1ml oral liquid contains crude drug 2g.Experimental animal is an ICR kind white mice, body weight 20g ± 2g, male and female half and half, totally 20.Test method is: fasting was pressed 20g/Kg and is given mice lavage 3 months after 12 hours, and the long term toxicity test result shows, the white mice body weight, and liver, renal function, hemogram etc. and matched group no significant difference show that the safety of this medicine is big, belong to nontoxic rank.

Claims (7)

1, a kind of medicine for the treatment of cranial nerve and cerebrovascular disease is characterized in that mainly being made by the crude drug of following parts by weight: Herba Taraxaci 10-35 part, Herba Taxilli 8-35 part, Rhizoma Chuanxiong 5-16 part, Lentinus Edodes 10-25 part, agrocyb eaegerita 10-30 part, Herba Saussureae Involueratae 12-24 part.
2, the medicine of treatment cranial nerve according to claim 1 and cerebrovascular disease is characterized in that also including in the crude drug Tremella of 5~30 parts by weight.
3, the medicine of treatment cranial nerve according to claim 1 and cerebrovascular disease is characterized in that the consumption of each crude drug is: 10~20 parts of Herba Taraxacis, 10~20 parts of Herba Taxillis, 8~15 parts of Rhizoma Chuanxiongs, 15~17 parts on Lentinus Edodes, 16~20 parts of agrocyb eaegerita, 15~18 parts of Herba Saussureae Involuerataes.
4, the medicine of treatment cranial nerve according to claim 3 and cerebrovascular disease is characterized in that also including in the crude drug Tremella of 10~15 parts by weight.
5, the medicine of treatment cranial nerve according to claim 4 and cerebrovascular disease is characterized in that the consumption of each crude drug is: 15 parts of Herba Taraxacis, 12 parts in Tremella, 15 parts of Herba Taxillis, 10 parts of Rhizoma Chuanxiongs, 16 parts on Lentinus Edodes, 18 parts of agrocyb eaegerita, 16 parts of Herba Saussureae Involuerataes.
6, a kind of preparation method for the treatment of the medicine of cranial nerve and cerebrovascular disease is characterized in that comprising the following steps:
1) standby by following parts by weight proportioning weighting raw materials: 5~30 parts in Tremella, Herba Taraxaci 10-35 part, Herba Taxilli 8-35 part, Rhizoma Chuanxiong 5-16 part, Lentinus Edodes 10-25 part, agrocyb eaegerita 10-30 part, Herba Saussureae Involueratae 12-24 part;
2) get Tremella, Lentinus Edodes, agrocyb eaegerita, Herba Saussureae Involueratae in proportion 1: 5 water mix, room temperature soak down 3~6 hours standby;
3) be incubated 40~120 minutes down at 50~80 ℃;
4) add Rhizoma Chuanxiong, Herba Taxilli, Herba Taraxaci, temperature is raised to 80~100 ℃, and slow fire boiled 1~3 hour;
5) filter, medicinal liquid is concentrated to 1/10 of total amount promptly can be made into oral liquid.
7, according to the preparation method of the medicine of described treatment cranial nerve of claim 6 and cerebrovascular disease, it is characterized in that comprising the following steps:
1) standby by following parts by weight proportioning weighting raw materials: 10~15 parts in Tremella, 10~20 parts of Herba Taraxacis, 10~20 parts of Herba Taxillis, 8~15 parts of Rhizoma Chuanxiongs, 15~17 parts on Lentinus Edodes, 16~20 parts of agrocyb eaegerita, 15~18 parts of Herba Saussureae Involuerataes;
2) get Tremella, Lentinus Edodes, agrocyb eaegerita, Herba Saussureae Involueratae in proportion 1: 5 water mix, room temperature soak down 4 hours standby;
3) be incubated 45 minutes down at 55~60 ℃;
4) add Rhizoma Chuanxiong, Herba Taxilli, Herba Taraxaci, temperature is raised to 90~100 ℃, and slow fire boiled 1~2 hour;
5) filter, medicinal liquid is concentrated to 1/10 of total amount promptly can be made into oral liquid.
CNB2005100429944A 2005-07-26 2005-07-26 Medication for treating diseases of cranial nerve and cerebrovascular, and preparation method Expired - Fee Related CN100528180C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100429944A CN100528180C (en) 2005-07-26 2005-07-26 Medication for treating diseases of cranial nerve and cerebrovascular, and preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100429944A CN100528180C (en) 2005-07-26 2005-07-26 Medication for treating diseases of cranial nerve and cerebrovascular, and preparation method

Publications (2)

Publication Number Publication Date
CN1726947A CN1726947A (en) 2006-02-01
CN100528180C true CN100528180C (en) 2009-08-19

Family

ID=35926586

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100429944A Expired - Fee Related CN100528180C (en) 2005-07-26 2005-07-26 Medication for treating diseases of cranial nerve and cerebrovascular, and preparation method

Country Status (1)

Country Link
CN (1) CN100528180C (en)

Also Published As

Publication number Publication date
CN1726947A (en) 2006-02-01

Similar Documents

Publication Publication Date Title
CN101732683A (en) Chinese medicinal preparation for treating facial chloasma and preparation method thereof
CN102727711B (en) Traditional Chinese medicine used for treating chronic fatigue syndrome
CN106579419A (en) Fatigue alleviating, physical strength restoring and energy replenishing functional food composition
CN109077321A (en) A kind of composition and preparation method thereof with strengthen immunity and antioxidation
CN102847061B (en) Traditional Chinese medicine preparation for treating pediatric viral myocarditis and preparation method thereof
CN104206595A (en) Blood lipid and blood glucose reducing Chinese wolfberry root-bark health care tea and preparation method thereof
CN101279034B (en) Combined Chinese medicament for curing diabetic with combined internal and external therapies and preparation thereof
CN105994867A (en) Chocolate with effect of improving immunity and preparation method thereof
CN106177166A (en) A kind of compositions with function of physical fatigue alleviation and preparation method thereof
CN101766799A (en) Ginseng-monkshood centipede health wine
CN103860773A (en) Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof
CN103816456A (en) Pharmaceutical composition for treating post-traumatic brain syndrome
CN104825956A (en) Medicine for preventing and treating stroke and recovering muscles, bones and joints
CN104524233B (en) A kind of BRM for promoting hematopoiesis function to improve immunity and its preparation and application
CN100528180C (en) Medication for treating diseases of cranial nerve and cerebrovascular, and preparation method
CN102908425A (en) Medicine for treating heart diseases and thick blood lipid and preparation method of the medicine
CN103495108B (en) Medicine for treating chronic hypotension and preparation method for medicine
CN102988747B (en) Aristida triseta electuary for reducing hypertension, hyperglycemia and hyperlipidemia and preparation method thereof
CN103520684B (en) Traditional Chinese medicine compound for reducing blood sugar
CN104524397A (en) Traditional Chinese medicine composition for assisted rehabilitation of stroke and preparation method of composition
CN104223062B (en) Root bark of Chinese wolf-berry health care oral liquid of a kind of reducing pressure and sugar and preparation method thereof
CN103272029A (en) Traditional Chinese medicine formula for curing hypertension
CN103405649B (en) External pharmaceutical composition for recovery after nervus peroneus communis injury
CN101983712A (en) Novel medicament for treating coronary heart disease
CN108210596B (en) Traditional Chinese medicine for reducing blood pressure and method for preparing plaster for reducing blood pressure by using traditional Chinese medicine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090819

Termination date: 20110726